Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Angiogenex Inc (OP: AGGX )

0.2500 USD UNCHANGED
Last Price Updated: 11:27 AM EST, Jan 14, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Angiogenex Inc

AngioGenex Co-Developping Anti-Cancer Drug with World Renowned Cancer Center
Tags technology c:germany banking/finance/investment
From EIN Presswire
AngioGenex Presents Data on its Id Targeted Anti-Angiogenesis Inhibitors at Two Scientific Conferences
From PR Newswire
AngioGenex Reviews 2008 Achievements and Sets Goals for 2009
From PR Newswire
AngioGenex Appoints New CEO to Direct Development of Anti-Cancer Drugs
From PR Newswire
Benezra Report in Nature Biotechnology Validates AngioGenex's Drug Development Platform by Demonstrating Tumor Suppression Through Id Protein Inhibition
From PR Newswire
William Garland Joins AngioGenex's New Board of Directors
From PR Newswire
AngioGenex European Listing Approved -- Company's Shares now Trading on the Frankfurt Stock Exchange under Symbol 'TLE'
From PR Newswire
AngioGenex, Inc. Engages London & Pacific Healthcare to Assist in Attracting Investment Funding
London & Pacific to Leverage Various Capital Resources in the Indian Healthcare Market 
From Marketwired News Releases
AngioGenex/BioCheck Collaboration Produces Novel Antibodies, Revenue and Progress toward a Cancer Diagnostic
From PR Newswire
AngioGenex Listing Approved-Trading Under Symbol AGGX.OB
From PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.